Refine your search:     
Report No.
 - 
Search Results: Records 1-4 displayed on this page of 4
  • 1

Presentation/Publication Type

Initialising ...

Refine

Journal/Book Title

Initialising ...

Meeting title

Initialising ...

First Author

Initialising ...

Keyword

Initialising ...

Language

Initialising ...

Publication Year

Initialising ...

Held year of conference

Initialising ...

Save select records

Journal Articles

Complexation of lutetium-177 with bifunctional chelators in the presence of Mg, Cu, and Yb

Watanabe, Satoshi; Hashimoto, Kazuyuki; Ishioka, Noriko

JAEA-Review 2014-050, JAEA Takasaki Annual Report 2013, P. 102, 2015/03

Journal Articles

Production of highly purified no-carrier-added $$^{177}$$Lu for radioimmunotherapy

Watanabe, Satoshi; Hashimoto, Kazuyuki; Watanabe, Shigeki; Iida, Yasuhiko*; Hanaoka, Hirofumi*; Endo, Keigo*; Ishioka, Noriko

Journal of Radioanalytical and Nuclear Chemistry, 303(1), p.935 - 940, 2015/01

 Times Cited Count:15 Percentile:73.03(Chemistry, Analytical)

Oral presentation

Complexation of $$^{177}$$Lu with bifunctional chelators in the presence of competing metals

Watanabe, Satoshi; Hashimoto, Kazuyuki; Ishioka, Noriko

no journal, , 

no abstracts in English

Oral presentation

Evaluation of Lu-177 production in the research reactor JRR-3

Fujino, Shunsuke; Hashimoto, Kazuyuki; Saeki, Hideya*; Kawauchi, Yukimasa*; Kawabata, Masako*; Chiba, Yusuke

no journal, , 

Lutetium-177 (Lu-177)is a medical radioisotope used in approved radiopharmaceutical "Lutathera" to treat neuroendocrine tumours. And it is one of the promising radionuclides for new therapeutic radiopharmaceuticals. However, Lu-177 is dependent on imports from overseas, and there are concerns that transportation problems etc. may affect domestic distribution and development of new pharmaceuticals. In order to confirm whether JAEA can produce a portion of the Lu-177 for research, we conducted a production test of Lu-177 using JRR-3.

4 (Records 1-4 displayed on this page)
  • 1